TS
MNTA

Twin Securities’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Twin Securities’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-122,500
Closed -$6.43M – 20
2020
Q3 		$6.43M Buy
+122,500
New +$5.07M 4.62% 5

Twin Securities's MNTA Position: Q4 2020 in Review

Twin Securities sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 122,500 shares — an estimated $6.43M sold.

Twin Securities first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $6.43M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Twin Securities reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Twin Securities sold 122,500 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $6.43M.
  • Twin Securities first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Twin Securities's Momenta Pharmaceuticals, Inc. position peaked at $6.43M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Twin Securities's 13F filing for Q4 2020, filed 16 Feb 2021.